In the late 1990s, scientists at the CSIRO invented a gene therapy that showed potential to treat incurable diseases such as hepatitis via a single injection.
The invention was acquired by Benitec Biopharma, listed on the Australian Securities Exchange and today has a value of about $70 million.
Loading...
John Kehoe is economics editor at Parliament House, Canberra. He writes on economics, politics and business. John was Washington correspondent covering Donald Trump’s first election. He joined the Financial Review in 2008 from Treasury. Connect with John on Twitter. Email John at jkehoe@afr.com
